Cabozantinib Fumarate is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. Reference standards of Cabozantinib Fumarate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Cabozantinib Fumarate - API Standards [catalogue_number] => PA 03 4690000 [category_ids] => ,78,70,82, [chemical_name] => [weight] => 617.59 [form] => C32H28FN3O9 [cas] => NA [pslug] => cabozantinib-fumarate-api-standards-pa034690000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 03 4690000
CAS :
Molecular Formula : C32H28FN3O9
Molecular Weight : 617.59
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....